TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma
- 8 March 2021
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 20 (5-6) , 603-615
Abstract
Retinoblastoma (RB) is commonly-seen cancer in children. The p53 pathway dysfunction, which can lead to elevated MDM2 or MDM4 (p53 antagonists) protein expression, is frequently observed in almost all human cancers, including RB. The present study attempted to investigate the underlying mechanism from the perspective of non-coding RNA regulation. Here, we demonstrated that p53 and miR-129 were positively correlated with each other in RB. miR-129 directly targeted MDM2/4 to inhibit expression, therefore counteracting MDM2/4-mediated p53 signaling suppression and modulating RB cell proliferation and apoptosis. Moreover, p53 could activate the transcription of miR-129 via binding to the miR-129 promoter region, therefore forming a regulatory loop with MDM2/4 to affect RB progression. Altogether, the p53/miR-129/MDM2/4/p53 regulatory loop can modulate RB cell growth. We provide a solid experimental basis for developing novel therapies for RB.Keywords
Funding Information
- Key Laboratory of Hunan Provincial Key Laboratory for Preventing and Treating Five Diseases of Obstetrics and Gynecology (2017TP1018)
- Science and Technology Plan of Changsha City (kc1704005)
- Science and Technology Plan of Changsha City (K1501014-31)
- Key Subject Construction Project of Traditional Chinese Medicine Ophthalmology of the State Administration of Traditional Chinese Medicine (ZK1801YK015)
This publication has 32 references indexed in Scilit:
- Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma developmentBMC Cancer, 2012
- Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3aCancer Research, 2011
- Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneProceedings of the National Academy of Sciences, 2009
- Inactivation of the p53 pathway in retinoblastomaNature, 2006
- Proteomimetic Libraries: Design, Synthesis, and Evaluation of p53−MDM2 Interaction InhibitorsJournal of Combinatorial Chemistry, 2006
- Genetic mutual relationship between PTEN and p53 in gastric cancerCancer Letters, 2005
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor ActivityMolecular and Cellular Biology, 2004
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastomaCancer Letters, 1996